©The Author(s) 2026.
World J Gastrointest Oncol. Feb 15, 2026; 18(2): 115404
Published online Feb 15, 2026. doi: 10.4251/wjgo.v18.i2.115404
Published online Feb 15, 2026. doi: 10.4251/wjgo.v18.i2.115404
Table 1 Comparison of basic characteristics of gastric cancer patients
| Characteristic | Total (n = 200) | No peritoneal metastasis | Peritoneal metastasis | Statistical value | P value |
| Age (years) | 63 (55, 71) | 61 (53, 69) | 66 (58, 74) | Z = -2.162 | 0.031 |
| Gender | χ2 = 0.892 | 0.345 | |||
| Male | 134 (67.0) | 89 (69.5) | 45 (62.5) | ||
| Female | 66 (33.0) | 39 (30.5) | 27 (37.5) | ||
| BMI (kg/m2) | 22.8 (20.5, 25.2) | 23.1 (20.8, 25.4) | 22.3 (19.9, 24.8) | Z = -1.423 | 0.155 |
| Clinical symptoms | |||||
| Abdominal pain | 156 (78.0) | 97 (75.8) | 59 (81.9) | χ2 = 1.098 | 0.295 |
| Abdominal distension | 89 (44.5) | 52 (40.6) | 37 (51.4) | χ2 = 2.284 | 0.131 |
| Weight loss | 124 (62.0) | 74 (57.8) | 50 (69.4) | χ2 = 2.745 | 0.098 |
| Anemia | 98 (49.0) | 58 (45.3) | 40 (55.6) | χ2 = 2.070 | 0.150 |
| Blood routine indicators | |||||
| Hemoglobin (g/L) | 118 (102, 135) | 124 (108, 142) | 108 (94, 126) | Z = -2.648 | 0.008 |
| White blood cell count | 6.8 (5.2, 8.9) | 6.3 (4.9, 8.1) | 7.6 (5.8, 9.8) | Z = -2.035 | 0.042 |
| Platelet count (× 109/L) | 285 (218, 356) | 268 (205, 338) | 312 (248, 389) | Z = -2.314 | 0.021 |
| Liver and kidney function indicators | |||||
| ALT (U/L) | 28 (18, 45) | 24 (16, 38) | 35 (22, 58) | Z = -2.187 | 0.029 |
| AST (U/L) | 32 (21, 48) | 28 (19, 42) | 38 (26, 61) | Z = -2.458 | 0.014 |
| Total bilirubin (μmol/L) | 18.6 (12.4, 26.8) | 16.2 (11.8, 23.4) | 22.8 (15.7, 32.1) | Z = -2.319 | 0.020 |
| Creatinine (μmol/L) | 78 (65, 94) | 74 (62, 89) | 85 (71, 102) | Z = -2.108 | 0.035 |
| Blood urea nitrogen (mmol/L) | 5.8 (4.2, 7.6) | 5.4 (4.0, 7.1) | 6.5 (4.8, 8.9) | Z = -1.892 | 0.058 |
| Laboratory indicators | |||||
| CEA (ng/mL) | 8.5 (3.2, 22.1) | 5.8 (2.6, 14.3) | 18.9 (8.7, 45.2) | Z = -5.834 | < 0.001 |
| CA19-9 (U/mL) | 45.2 (18.7, 126.8) | 28.4 (15.2, 78.6) | 89.7 (42.3, 234.1) | Z = -4.921 | < 0.001 |
| CA72-4 (U/mL) | 12.6 (4.8, 35.7) | 7.9 (3.8, 21.4) | 28.4 (12.1, 68.9) | Z = -5.127 | < 0.001 |
| Tumor differentiation degree | χ2 = 12.358 | 0.002 | |||
| Well differentiated | 23 (11.5) | 20 (15.6) | 3 (4.2) | ||
| Moderately differentiated | 89 (44.5) | 64 (50.0) | 25 (34.7) | ||
| Poorly differentiated | 88 (44.0) | 44 (34.4) | 44 (61.1) | ||
| Lauren classification | χ2 = 15.942 | < 0.001 | |||
| Intestinal type | 78 (39.0) | 61 (47.7) | 17 (23.6) | ||
| Diffuse type | 95 (47.5) | 52 (40.6) | 43 (59.7) | ||
| Mixed type | 27 (13.5) | 15 (11.7) | 12 (16.7) | ||
| HER-2 expression | χ2 = 5.624 | 0.018 | |||
| Negative | 142 (71.0) | 85 (66.4) | 57 (79.2) | ||
| Positive | 58 (29.0) | 43 (33.6) | 15 (20.8) |
- Citation: Mu XD, Ji DX, Kang DQ. Application value of multiphase contrast-enhanced computed tomography radiomics in preoperative evaluation of peritoneal metastasis in gastric cancer. World J Gastrointest Oncol 2026; 18(2): 115404
- URL: https://www.wjgnet.com/1948-5204/full/v18/i2/115404.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i2.115404